Podcasts

Episode 44 | Large Cell Neuroendocrine Carcinoma of the Lung: Challenges in Diagnosis and Treatment

A/Prof Rachel Wong is joined by Dr Patrick Hosking, Dr Mal Itchins, and Dr Sagun Parakh discuss the diagnostic markers when identifying LC-NEC.

Episode Summary

In this episode, we discuss the clinical and diagnostic markers when identifying a rare sub type of NSCLC, large-cell neuroendocrine carcinomas (LC-NEC), and provide insights into the management of these patients and future treatment developments.

This podcast episode is sponsored by Boehringer Ingelheim.

Show Hosts

A/Prof Rachel Wong, Deputy Director Oncology Eastern Health and Medical Oncologist at Epworth East in Melbourne
Dr Patrick Hosking, Senior Histopathologist at Eastern Health Pathology
Dr Mal Itchins, Thoracic Medical Oncologist at Royal North Shore Hospital and Chris O’Brien LifeHouse in Sydney
Dr Sagun Parakh, Medical Oncologist at the Austin Hospital, Lung Cancer Lead

Play Episode 44 | Large Cell Neuroendocrine Carcinoma of the Lung: Challenges in Diagnosis and Treatment

More Podcasts

46 – Navigating Resistance in ALK-Positive NSCLC Patients on TKI Therapy

Podcasts
December 13, 2024

Dr Rebecca Tay is joined by Professor Ben Solomon and A/Prof Michael Ng to discuss clinical and genetic factors affecting treatment choice for ALK-Positive NSCLC

45 – The Case For IO in Early-Stage NSCLC in a Once in a Lifetime World

Podcasts
December 2, 2024

Dr Deme Karikios is joined by Dr Lauren Brown and Dr Stephen Barnett to discuss IO in early-stage NSCLC in the Australian context.

43 – Management of Limited-Stage Small Cell Lung Cancer

Podcasts
October 1, 2024

We dive into the latest survival data from the ADRIATIC trial, as presented at ASCO 2024, which could change the treatment landscape for LS-SCLC. Joining

42 – NTRK 1, 2, 3 and Other Rare Mutations in NSCLC

Podcasts
August 30, 2024

This episode is hosted by: A/Prof Steven Kao, Prof Wendy Cooper, and Prof Ben Solomon

41 – Decoding Perioperative Immunotherapy In NSCLC

Podcasts
July 30, 2024

This episode is hosted by: Dr Pei Ni Ding, Dr Samantha Bowyer, and Mr Naveed Alam.

40 – Access to New Medicines: Which Surrogate Endpoints Matter

Podcasts
July 30, 2024

This episode is hosted by: Dr Rebecca Tay, Professor Nick Pavlakis, and Dr Deme Karikios.

Join our community – stay up to date with the latest research, TOGA news and events

The Thoracic Oncology Group of Australasia Limited acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait cultures; and to Elders past and present.

Contact

PO Box 1103
Thornbury VIC 3071
Ph: +61 3 9087 3550
ABN: 47 641 984 198

TOGA

Quicklinks

Thoracic Oncology Group of Australasia is registered with the Australian Taxation Office as an Income Tax Exempt Charitable Entity. Donations $2 and over are tax deductible.